French drugmaker Sanofi (NASDAQ: SNY) is at the forefront when it comes to the development of a coronavirus treatment or vaccine, and yet its shares haven’t benefited from the efforts. While Sanofi …
More Why Sanofi’s Coronavirus Vaccine Work Hasn’t Helped Its Stock Videos